{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Frigerio I"],"funding":["National Institute for Health Research (NIHR)","Michael J. Fox Foundation for Parkinson's Research"],"pagination":["3"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9854202"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(1)"],"pubmed_abstract":["Increased neurofilament levels in biofluids are commonly used as a proxy for neurodegeneration in several neurodegenerative disorders. In this study, we aimed to investigate the distribution of neurofilaments in the cerebral cortex of Parkinson's disease (PD), PD with dementia (PDD) and dementia with Lewy bodies (DLB) donors, and its association with pathology load and MRI measures of atrophy and diffusivity. Using a within-subject post-mortem MRI-pathology approach, we included 9 PD, 12 PDD/DLB and 18 age-matched control donors. Cortical thickness and mean diffusivity (MD) metrics were extracted respectively from 3DT1 and DTI at 3T in-situ MRI. After autopsy, pathological hallmarks (pSer129-αSyn, p-tau and amyloid-β load) together with neurofilament light-chain (NfL) and phosphorylated-ne"],"journal":["Translational neurodegeneration"],"pubmed_title":["Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson's disease dementia."],"pmcid":["PMC9854202"],"funding_grant_id":["17253"],"pubmed_authors":["Hepp DH","Galis-de Graaf Y","Bol JGJM","Lin CP","van de Berg WDJ","Bouwman MMA","Rozemuller AJM","Frigerio I","Laansma MA","Barkhof F","Hermans EJM","Jonkman LE"],"additional_accession":[]},"is_claimable":false,"name":"Neurofilament light chain is increased in the parahippocampal cortex and associates with pathological hallmarks in Parkinson's disease dementia.","description":"Increased neurofilament levels in biofluids are commonly used as a proxy for neurodegeneration in several neurodegenerative disorders. In this study, we aimed to investigate the distribution of neurofilaments in the cerebral cortex of Parkinson's disease (PD), PD with dementia (PDD) and dementia with Lewy bodies (DLB) donors, and its association with pathology load and MRI measures of atrophy and diffusivity. Using a within-subject post-mortem MRI-pathology approach, we included 9 PD, 12 PDD/DLB and 18 age-matched control donors. Cortical thickness and mean diffusivity (MD) metrics were extracted respectively from 3DT1 and DTI at 3T in-situ MRI. After autopsy, pathological hallmarks (pSer129-αSyn, p-tau and amyloid-β load) together with neurofilament light-chain (NfL) and phosphorylated-ne","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2025-04-22T08:48:10.899Z","creation":"2025-02-19T01:08:15.861Z"},"accession":"S-EPMC9854202","cross_references":{"pubmed":["36658627"],"doi":["10.1186/s40035-022-00328-8"]}}